Takeda taps Schrödinger for drug discovery | July 31, 2017 Issue - Vol. 95 Issue 31 | Chemical & Engineering News
Volume 95 Issue 31 | p. 17 | Concentrates
Issue Date: July 31, 2017

Takeda taps Schrödinger for drug discovery

Department: Business
Keywords: Informatics, computational drug discovery, collaboration, license

Takeda Pharmaceutical has entered a multitarget research collaboration with Schrödinger, a computational science firm. In an effort led by Schrödinger, the Japanese drug firm will provide protein crystal structures to guide the in silico design of new chemical entities in areas of therapeutic interest. Takeda has the option to license compounds from Schrödinger, paying up to $170 million per compound as well as royalties on future sales.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment